Issued 2026-09-16 at $271.34 · now $271.34 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, ESS has typically landed between $243.22 and $295.63 — a range of −10.4% to +9.0% from the issuance price $271.34.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,685 overlapping 1 month windows · 2008-01-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($271.34) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where ESS has typically landed a month from the 2026-09-16 close of $271.34 — the range is history, not a prediction.
- now $271.34 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $273.26 (+0.7%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $262.6–$283.91
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $243.22–$295.63
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-21 | −44.6% | −44.6% | +0.0% |
| 2020-02-24 | −42.3% | −44.1% | +0.0% |
| 2020-02-20 | −39.8% | −39.8% | +0.9% |
| 3 best | |||
| 2020-03-23 | +35.5% | +0.0% | +44.5% |
| 2020-10-28 | +34.2% | +0.0% | +41.1% |
| 2020-10-19 | +30.6% | −6.4% | +32.1% |
4,685 overlapping windows · 2008-01-02 – 2026-09-16 · not cherry-picked
Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.
Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.
iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 29 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.- DCF (intrinsic)$738.69
- Peer P/E × EPS · sector median 32.9× · n=29$292.57
- Analyst target · range $278.00–$352.00$296.50
- Current price · last close 2026-09-16$271.34
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | Kasaris Mary | director | Sale | 600 @ $279.45 | $168K | −20.0% of holding | +9.3% | not yet — horizon still open | 2,394 | Form 4 · filed 2 days after the trade |
| 2025-03-11 | Kasaris Mary | director | Sale | 2,800 @ $300.80 | $842K | −61.5% of holding | −6.2% | −27.2% | 1,755 | Form 4 · filed 2 days after the trade |
| 2025-03-04 | Kleiman Angela L. | director | Sale | 400 @ $315.12 | $126K | −2.8% of holding | +2.6% | −25.7% | 13,662 | Form 4 · filed 1 day after the trade |
| 2025-03-03 | GUERICKE KEITH R | director | Sale | 7,298 @ $315.00 | $2.3M | −31.2% of holding | +1.8% | −25.8% | 16,118 | Form 4 · filed 2 days after the trade |
| 2025-03-03 | Pak Barbara | officer | Sale | 6,318 @ $314.79 | $2.0M | −42.2% of holding | +1.8% | −25.8% | 8,654 | Form 4 · filed 2 days after the trade |
| 2025-03-03 | Kleiman Angela L. | director | Sale | 4,929 @ $314.99 | $1.6M | −26.5% of holding | +1.8% | −25.8% | 13,662 | Form 4 · filed 2 days after the trade |
| 2025-03-03 | Morrison Anne | officer | Sale | 2,571 @ $314.79 | $809K | −43.1% of holding | +1.8% | −25.8% | 3,389 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
76 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-05-12 | Kasaris Mary | director | Award / grant | 633 | 2,994 | Form 4 |
| 2026-05-12 | LYONS IRVING F III | director | Award / grant | 633 | 9,809 | Form 4 |
| 2026-05-12 | Arabia John V | director | Award / grant | 633 | 1,824 | Form 4 |
| 2026-05-12 | MARCUS GEORGE M | director | Award / grant | 1,117 | 223,042 | Form 4 |
| 2026-05-12 | GUERICKE KEITH R | director | Award / grant | 633 | 17,357 | Form 4 |
| 2026-05-12 | GUST ANNE B | director | Award / grant | 633 | 1,830 | Form 4 |
| 2026-05-12 | Johnson Amal M | director | Award / grant | 633 | 3,824 | Form 4 |
| 2026-05-12 | HAWTHORNE MARIA R | director | Award / grant | 633 | 3,711 | Form 4 |
| 2026-02-18 | Kleiman Angela L. | director | Withheld for tax | 481 | 21,972 | Form 4 |
| 2026-02-18 | Pak Barbara | officer | Withheld for tax | 206 | 12,239 | Form 4 |
| 2026-02-18 | Burns Rylan | officer | Withheld for tax | 121 | 2,232 | Form 4 |
| 2026-02-18 | Morrison Anne | officer | Withheld for tax | 89 | 6,880 | Form 4 |
| 2026-02-18 | McGreevy Brennan | officer | Withheld for tax | 24 | 715 | Form 4 |
| 2026-02-06 | Kleiman Angela L. | director | Withheld for tax | 473 | 22,453 | Form 4 |
| 2026-02-06 | Pak Barbara | officer | Withheld for tax | 215 | 12,445 | Form 4 |
| 2026-02-06 | Morrison Anne | officer | Withheld for tax | 81 | 6,969 | Form 4 |
| 2026-02-06 | Burns Rylan | officer | Withheld for tax | 80 | 2,353 | Form 4 |
| 2026-02-06 | McGreevy Brennan | officer | Withheld for tax | 60 | 739 | Form 4 |
| 2025-12-29 | Kleiman Angela L. | director | Gift | 2,534 | 22,926 | Form 4 |
| 2025-12-12 | Kleiman Angela L. | director | Withheld for tax | 12,176 | 25,460 | Form 4 |
| 2025-12-12 | Pak Barbara | officer | Withheld for tax | 4,138 | 12,660 | Form 4 |
| 2025-12-12 | Morrison Anne | officer | Withheld for tax | 3,780 | 7,050 | Form 4 |
| 2025-12-12 | Kleiman Angela L. | director | Award / grant | 23,974 | 37,636 | Form 4 |
| 2025-12-12 | Morrison Anne | officer | Award / grant | 7,441 | 10,830 | Form 4 |
| 2025-12-12 | Pak Barbara | officer | Award / grant | 8,144 | 16,798 | Form 4 |
| 2025-12-09 | Burns Rylan | officer | Withheld for tax | 178 | 2,433 | Form 4 |
| 2025-12-09 | McGreevy Brennan | officer | Withheld for tax | 28 | 799 | Form 4 |
| 2025-05-28 | MARCUS GEORGE M | director | Option exercise | 13,418 | 221,925 | Form 4 |
| 2025-05-28 | MARCUS GEORGE M | director | Option exercise | 13,418 | 0 | Form 4 |
| 2025-05-22 | LYONS IRVING F III | director | Other acquisition | 585 | 9,176 | Form 4 |
| 2025-05-22 | LYONS IRVING F III | director | Other acquisition | 585 | 585 | Form 4 |
| 2025-05-13 | Arabia John V | director | Award / grant | 606 | 1,191 | Form 4 |
| 2025-05-13 | Kasaris Mary | director | Award / grant | 606 | 2,361 | Form 4 |
| 2025-05-13 | GUST ANNE B | director | Award / grant | 606 | 1,191 | Form 4 |
| 2025-05-13 | MARCUS GEORGE M | director | Award / grant | 1,069 | 208,507 | Form 4 |
| 2025-05-13 | HAWTHORNE MARIA R | director | Award / grant | 606 | 3,078 | Form 4 |
| 2025-05-13 | GUERICKE KEITH R | director | Award / grant | 606 | 16,724 | Form 4 |
| 2025-05-13 | Johnson Amal M | director | Award / grant | 606 | 3,191 | Form 4 |
| 2025-05-13 | LYONS IRVING F III | director | Award / grant | 606 | 9,761 | Form 4 |
| 2025-03-11 | Kasaris Mary | director | Option exercise | 2,800 | 4,555 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.
As of 2026-09-16 · point-in-time by filed date
A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).
| Member | Chamber | Type | Filed | Traded | Size |
|---|---|---|---|---|---|
| Alan Armstrong | Senate | purchase | 2026-07-21 | 2026-03-27 | $1–15K |
| Ro Khanna | House | purchase | 2026-04-07 | 2026-03-23 | $1–15K |
| Ro Khanna | House | sale | 2026-03-09 | 2026-02-05 | $1–15K |
| Ro Khanna | House | purchase | 2026-02-06 | 2026-01-29 | $1–15K |
| Ro Khanna | House | sale | 2026-02-06 | 2026-01-13 | $1–15K |
| Rick Larsen | House | sale | 2026-01-14 | 2026-01-07 | $1–15K |
| Ro Khanna | House | sale | 2025-09-09 | 2025-08-26 | $1–15K |
| Ro Khanna | House | purchase | 2025-09-09 | 2025-08-04 | $1–15K |
| Ro Khanna | House | sale | 2025-09-09 | 2025-08-26 | $1–15K |
| Ro Khanna | House | purchase | 2025-09-09 | 2025-08-04 | $1–15K |
| Ro Khanna | House | purchase | 2025-06-10 | 2025-05-19 | $1–15K |
| Daniel Goldman | House | sale | 2023-08-13 | 2023-07-12 | $15–50K |
| Ro Khanna | House | sale | 2023-06-12 | 2023-05-23 | $1–15K |
| Rick Larsen | House | purchase | 2023-05-26 | 2021-07-07 | $1–15K |
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.